TECAN LIMITED

Location

Founded

Website

Risk Signals

224 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Fabricated Structural Metal, Miscellaneous Structural Metal Work, Fabricated Metal Products, Not Elsewhere Classified, Manufacturing Industries, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about TECAN LIMITED

Live alerts from global media, monitored by Business Radar

A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology

2024-09-30 (biomedcentral.com)

A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology

Immunotherapy has shown marked progress in promoting systemic anti-colorectal cancer (CRC) clinical effects. For further effectively sensitizing CRC to immunotherapy, we have engineered a pH-sensitive zeolitic imidazolate framework-8( CS/NPs), capable of efficient cGAS-STING pathway activation and

Read more
Tecan expands presence in the US with new distribution agreement for detection instruments

2024-06-28 (selectscience.net)

Tecan expands presence in the US with new distribution agreement for detection instruments

This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities

Read more
Tecan expands presence in the US with new distribution agreement for detection instruments

2024-06-28 (selectscience.net)

Tecan expands presence in the US with new distribution agreement for detection instruments

This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities

Read more
Tecan : DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. | MarketScreener

2023-04-11 (marketscreener.com)

Tecan : DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. | MarketScreener

April 11, 2023|Customer News DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. ... | April 11, 2023

Read more
Tecan : DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. | MarketScreener

2023-04-11 (marketscreener.com)

Tecan : DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. | MarketScreener

April 11, 2023|Customer News DYNEX Technologies and Tecan Partnership Expands Availability of ELISA Immunoassays in the U.S. ... | April 11, 2023

Read more
Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables

2020-08-21 (pharmiweb.com)

Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables

Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US.

Read more
Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables

2020-08-21 (pharmiweb.com)

Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables

Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US.

Read more
Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways   Communications

2020-07-03 (nature.com)

Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways Communications

The early life human gut microbiota exerts life-long health effects on the host, but the mechanisms underpinning its assembly remain elusive. Particularly, the early colonization of Clostridiales from the Roseburia-Eubacterium group, associated with protection from colorectal cancer, immune- and metabolic disorders is enigmatic. Here, we describe catabolic pathways that support the growth of Roseburia and Eubacterium members on distinct human milk oligosaccharides (HMOs). The HMO pathways, which include enzymes with a previously unknown structural fold and specificity, were upregulated together with additional glycan-utilization loci during growth on selected HMOs and in co-cultures with Akkermansia muciniphila on mucin, suggesting an additional role in enabling cross-feeding and access to mucin O-glycans. Analyses of 4599 Roseburia genomes underscored the preponderance and diversity of the HMO utilization loci within the genus.

Read more

Never miss a headline about TECAN LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages